Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Federal Rules of Evidence, Rule 502, at September 26, 2007

Federal Rules of Evidence, Rule 502, at September 26, 2007

posted on Oct 08, 2007 07:14AM

Is this to be the basis for attorney-client privilege and possible delay?

http://www.uscourts.gov/rules/Hill_Letter_re_EV_502.pdf

 

 

 

Be well

Share
New Message
Please login to post a reply